Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model

REFERENCES

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al.: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 2893–2917, 2010.
   PubMed Web of Science ®Google Scholar
• Mazzocca A and Carloni V: The metastatic process: methodological advances and pharmacological challenges. Curr Med Chem 16, 1704–1717, 2009.
   PubMed Web of Science ®Google Scholar
• Russak JE and Rigel DS: Risk factors for the development of primary cutaneous melanoma. Dermatol Clin 30, 363–368, 2012.
   PubMed Web of Science ®Google Scholar
• Lucas R: Global Burden of Disease of Solar Ultraviolet Radiation, Environmental Burden of Disease Series, No. 13 [News release]. Geneva, Switzerland: World Health Organization, 2006.
   Google Scholar
• Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, et al.: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27, 6199–6206, 2009.
   PubMed Web of Science ®Google Scholar
• Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12, 895–904, 2006.
   PubMed Web of Science ®Google Scholar
• McCawley LJ and Matrisian LM: Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6, 149–156, 2000.
   PubMedGoogle Scholar
• Yang JM, Xu Z, Wu H, Zhu H, Wu X, et al.: Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 1, 420–427 2003.
   PubMed Web of Science ®Google Scholar
• Cheng CY, Hsieh HL, Hsiao LD, and Yang CM: PI3-K/Akt/JNK/NF-kappaB is essential for MMP-9 expression and outgrowth in human limbal epithelial cells on intact amniotic membrane. Stem Cell Res 9, 9–23, 2012.
   PubMed Web of Science ®Google Scholar
• Shih YW, Chen PS, Wu CH, Jeng YF, and Wang CJ: Alpha-chaconine-reduced metastasis involves a PI3 K/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells. J Agric Food Chem 55, 11035–11043, 2007.
   PubMed Web of Science ®Google Scholar
• Lee YC, Cheng TH, Lee JS, Chen JH, Liao YC, et al.: Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3 K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell Biochem 347, 103–115, 2011.
   PubMed Web of Science ®Google Scholar
• Cantley LC and Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 96, 4240–4245, 1999.
   PubMed Web of Science ®Google Scholar
• Su Y, Gao L, Teng L, Wang Y, Cui J, et al.: Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3 K/Akt and NF-kappaB/MMP-2 signaling pathways. J Transl Med 11, 132, 2013.
   Web of Science ®Google Scholar
• Loehrer PJ and Einhorn LH: Drugs five years later. Cisplatin. Ann Intern Med 100, 704–713, 1984.
   PubMed Web of Science ®Google Scholar
• GuÈven. K, Kittler. H, Wolff. K, and Pehamberger H: Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant. Melanoma Research 11, 411–415, 2001.
   PubMed Web of Science ®Google Scholar
• Romagnolo DF and Selmin OI: Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 31, 206–238, 2012.
   PubMedGoogle Scholar
• Sen T, Moulik S, Dutta A, Choudhury PR, Banerji A, et al.: Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci 84, 194–204, 2009.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhu CF, Iwamoto H, and Chen JS: Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J Gastroenterol 11, 6512–6517, 2005
   PubMed Web of Science ®Google Scholar
• Falcao MJ, Pouliquem YB, Lima MA, Gramosa NV, Costa-Lotufo LV, et al.: Cytotoxic flavonoids from Platymiscium floribundum. J Nat Prod 68, 423–426, 2005.
   PubMed Web of Science ®Google Scholar
• Xie SR, Wang Y, Liu CW, Luo K, and Cai YQ: Liquiritigenin inhibits serum-induced HIF-1alpha and VEGF expression via the AKT/mTOR-p70S6 K signalling pathway in HeLa cells. Phytother Res 26, 1133–1141, 2012.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie S, Liu C, Wu Y, Liu Y, et al.: Inhibitory effect of liquiritigenin on migration via downregulation proMMP-2 and PI3 K/Akt signaling pathway in human lung adenocarcinoma A549 cells. Nutr Cancer 64, 627–634, 2012.
   PubMed Web of Science ®Google Scholar
• Roy R, Yang J, and Moses MA: Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27, 5287–5297, 2009.
   PubMed Web of Science ®Google Scholar
• Atkins MB, Lee S, Flaherty LE, Sosman JA, Sondak VK, et al.: A prospective randomized phase III trial of concurrent biochemotherapy (BCT) with cisplatin, vinblastine, dacarbazine (CVD), IL-2 and interferon alpha-2b (IFN) versus CVD alone in patients with metastatic melanoma (E3695): an ECOG-coordinated intergroup trial [abstract 2847]. Proc Am Soc Clin Oncol 22, 708, 2003.
   Google Scholar
• Dua P, Ingle A, and Gude RP: Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma. Int J Cancer 121, 1600–1608, 2007.
   PubMed Web of Science ®Google Scholar
• Lee TK, Poon RT, Wo JY, Ma S, Guan XY, et al.: Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Cancer Res 67, 8800–8809, 2007.
   PubMed Web of Science ®Google Scholar
• Liu X, Chan SY, and Ho PC: Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma. Cancer Chemother Pharmacol 63, 167–174, 2008.
   PubMed Web of Science ®Google Scholar
• Curran S and Murray GI: Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36, 1621–1630, 2000.
   PubMed Web of Science ®Google Scholar
• Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10, 415–433, 2000.
   PubMed Web of Science ®Google Scholar
• Zhang XM, Huang SP, and Xu Q: Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother Pharmacol 53, 82–88, 2004.
   PubMed Web of Science ®Google Scholar
• Lu Z, Lu N, Li C, Li F, Zhao K, et al.: Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. Toxicol Lett 209, 211–220, 2012.
   PubMed Web of Science ®Google Scholar
• Ramer R, Eichele K, and Hinz B: Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells. Oncogene 26, 5822–5827, 2007.
   PubMed Web of Science ®Google Scholar
• Hijova E: Matrix metalloproteinases: their biological functions and clinical implications. Bratisl Lek Listy 106, 127–132, 2005.
   PubMedGoogle Scholar
• Stettner R, Bogusiewicz M, and Rechberger T: [Matrix metalloproteinases and their inhibitors in ovarian cancer progression – diagnostic and therapeutic implications]. Ginekol Pol 80, 47–53, 2009.
   PubMed Web of Science ®Google Scholar
• Engelman JA: Targeting PI3 K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9, 550–562, 2009.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, and Bilanges B: The emerging mechanisms of isoform-specific PI3 K signalling. Nat Rev Mol Cell Biol 11, 329–341, 2010.
   PubMed Web of Science ®Google Scholar
• Yajima I, Kumasaka MY, Thang ND, Goto Y, Takeda K, et al.: RAS/RAF/MEK/ERK and PI3 K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy. Dermatol Res Pract 2012, 354191, 2012.
   PubMedGoogle Scholar
• Stahl JM, Cheung M, and Sharma A: Loss of PTEN promotes tumor development in malignant melanoma. Cancer Res 63, 2881–2890, 2003
   PubMed Web of Science ®Google Scholar
• Robertson GP: Functional and therapeutic significance of Akt deregulation in malignant. Cancer and Metastasis 24, 273–285, 2005
   PubMed Web of Science ®Google Scholar
• Shin DY, Lu JN, Kim GY, Jung JM, Kang HS, et al.: Anti-invasive activities of anthocyanins through modulation of tight junctions and suppression of matrix metalloproteinase activities in HCT-116 human colon carcinoma cells. Oncol Rep 25, 567–572, 2011.
   PubMed Web of Science ®Google Scholar
• Karam AK, Santiskulvong C, Fekete M, Zabih S, Eng C, et al.: Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression. Cytoskeleton (Hoboken) 67, 535–544, 2010.
   PubMed Web of Science ®Google Scholar